# Kimberly Cooper

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kimberly-cooper/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,133 |
| Field | Treatment of Major Depression |
| h-index | 18 |
| i10-index | 22 |
| Last Known Institution | Johnson & Johnson (United States) |
| OpenAlex ID | https://openalex.org/A5103850534 |
| Works | 35 |

## Researcher papers

- [Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study](https://scholariq.org/papers/efficacy-and-safety-of-flexibly-dosed-esketamine-nasal-spray-combined-with-a/)
- [Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression](https://scholariq.org/papers/efficacy-and-safety-of-intranasal-esketamine-adjunctive-to-oral-antidepressant/)
- [A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression](https://scholariq.org/papers/a-double-blind-randomized-placebo-controlled-dose-frequency-study-of-intravenous/)
- [Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder](https://scholariq.org/papers/multisite-controlled-study-of-oros-methylphenidate-in-the-treatment-of/)
- [Does Prolonged Therapy With a Long-Acting Stimulant Suppress Growth in Children With ADHD?](https://scholariq.org/papers/does-prolonged-therapy-with-a-long-acting-stimulant-suppress-growth-in-children/)
- [Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder](https://scholariq.org/papers/randomized-clinical-study-of-a-histamine-h3-receptor-antagonist-for-the/)
- [Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant](https://scholariq.org/papers/meaningful-change-in-depression-symptoms-assessed-with-the-patient-health/)
- [A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders](https://scholariq.org/papers/a-comparison-of-impulsivity-depressive-symptoms-lifetime-stress-and-sensation/)
- [Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials](https://scholariq.org/papers/retrospective-analysis-of-transient-elevations-in-alanine-aminotransferase/)
- [Treatment of general tension: Subjective and physiological effects of progressive relaxation.](https://scholariq.org/papers/treatment-of-general-tension-subjective-and-physiological-effects-of-progressive/)

## Researcher topics

- [Treatment of Major Depression](https://scholariq.org/topics/treatment-of-major-depression/)
- [Attention Deficit Hyperactivity Disorder](https://scholariq.org/topics/attention-deficit-hyperactivity-disorder/)
- [Neurotransmitter Receptor Influence on Behavior](https://scholariq.org/topics/neurotransmitter-receptor-influence-on-behavior/)
- [Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes](https://scholariq.org/topics/anxiety-depression-psychometrics-treatment-cognitive-processes/)
- [Substance Abuse Treatment and Outcomes](https://scholariq.org/topics/substance-abuse-treatment-and-outcomes/)

## Researcher university

- [Johnson & Johnson (United States)](https://scholariq.org/institutions/johnson-and-johnson-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.